Whole genome sequence analysis of Shigella from Malawi identifies fluoroquinolone resistance

George E Stenhouse1, Khuzwayo C Jere1,2,3, Chikondi Peno2

  • 1University of Liverpool, Liverpool, UK.

Microbial Genomics
|May 4, 2021
PubMed

Insights

Fluoroquinolone-resistant Shigella strains are a global health threat. Researchers identified the qnrS1 gene, a key factor in fluoroquinolone resistance, in Shigella isolates from Malawi.

Area of Science:

  • Microbiology
  • Genetics
  • Public Health

Background:

  • Antimicrobial resistance is a growing global health concern, necessitating research into resistant bacterial strains.
  • The World Health Organization has listed fluoroquinolone-resistant Shigella as a priority pathogen due to limited treatment options.

Purpose of the Study:

  • To characterize Shigella isolates from Malawi using whole genome sequencing.
  • To identify specific genetic determinants of fluoroquinolone resistance in these isolates.

Main Methods:

  • Whole genome sequencing of multiple Shigella isolates from Malawi.
  • Bioinformatic analysis to identify resistance genes.

Main Results:

  • Identification of the qnrS1 gene, an acquired fluoroquinolone resistance determinant, in the studied Shigella isolates.
  • Genomic characterization of Shigella strains from Malawi.

Conclusions:

  • The presence of the qnrS1 gene contributes to fluoroquinolone resistance in Shigella strains from Malawi.
  • Understanding resistance mechanisms is crucial for developing effective treatment strategies against priority pathogens.